The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Complications of intravitreal injections
Abstract
PURPOSE OF REVIEW: Over the past few years, the results of many studies have highlighted the risks and benefits of intravitreal injection of a number of medications, the most common being triamcinolone, antivascular endothelial growth factor (VEGF) agents, antibiotics, antivirals, antifungals, and methotrexate. The purpose of this review is to highlight the complications associated with these injections. RECENT FINDINGS: Elevated intraocular pressure and glaucoma are the most common complications of intraocular triamcinolone. There is also an increased incidence of cataract formation/progression over time. The immunosuppressive effect of triamcinolone does not appear to increase the risk of endophthalmitis. Recent reports suggest that intravitreal anti-VEGF injections have a low complication rate. Similarly, antimicrobials also have low rates of injection-associated complications. SUMMARY: Intravitreal injections play a critical role in daily ophthalmic practice. The overall risk of endophthalmitis and retinal detachment appears to be low and most of the commonly used drugs are well tolerated, even with repeat injection. Further long-term studies need to be performed to elucidate ways of increasing the safety of these procedures and medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Brown, D. M., Michels, M., Kaiser, P. K., Heier, J. S., Sy, J. P., & Ianchulev, T. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.10.018 · Cited by 1,318
Intravitreal triamcinolone for refractory diabetic macular edema
Martidis, A., Duker, J. S., Greenberg, P. B., Rogers, A. H., Puliafito, C. A., Reichel, E., & Baumal, C. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)00975-2 · Cited by 1,032
Regillo, C. D., Brown, D. M., Abraham, P., Yue, H., Ianchulev, T., Schneider, S., & Shams, N. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.10.004 · Cited by 858
(2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.234 · Cited by 674
RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW
JAGER, R. D., AIELLO, L. P., PATEL, S. C., & CUNNINGHAM, E. T. (2004) · Retina · doi:10.1097/00006982-200410000-00002 · Cited by 572
The SCORE Study Research Group* (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.233 · Cited by 458
Wu, L., Martínez-Castellanos, M. A., Quiroz-Mercado, H., Arevalo, J. F., Berrocal, M. H., Farah, M. E., Maia, M., Roca, J. A., Rodriguez, F. J., & for the Pan American Collaborative Retina Group (PACORES) (2007) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0660-z · Cited by 456
Intraocular pressure after intravitreal injection of triamcinolone acetonide
Jonas, J. B. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.1.24 · Cited by 422
(2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2008.610 · Cited by 398
Acute endophthalmitis following intravitreal triamcinolone acetonide injection
Moshfeghi, D. M., Kaiser, P. K., Scott, I. U., Sears, J. E., Benz, M., Sinesterra, J. P., Kaiser, R. S., Bakri, S. J., Maturi, R. K., Belmont, J., et al. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00483-5 · Cited by 397
Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis
Young, S., Larkin, G., Branley, M., & Lightman, S. (2001) · Clinical & Experimental Ophthalmology · doi:10.1046/j.1442-9071.2001.00360.x · Cited by 352
Treatment of Intraocular Proliferation with Intravitreal Injection of Triamcinolone Acetonide
Tano, Y., Chandler, D., & Machemer, R. (1980) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)75196-7 · Cited by 338
Intraocular Pressure Elevation After Intravitreal Triamcinolone Acetonide Injection
JONAS, J., DEGENRING, R., KREISSIG, I., AKKOYUN, I., & KAMPPETER, B. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.10.042 · Cited by 323
Intravitreal triamcinolone acetonide and intraocular pressure
Smithen, L. M., Ober, M. D., Maranan, L., & Spaide, R. F. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.06.067 · Cited by 296
Safety of an Intravitreal Injection of Triamcinolone: Results From a Randomized Clinical Trial
Gillies, M. C. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.3.336 · Cited by 291
Noninfectious Endophthalmitis Associated With Intravitreal Triamcinolone Injection
Roth, D. B. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.9.1279 · Cited by 285
Smith, J. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01125-9 · Cited by 277
Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience
Frenkel, S., Hendler, K., Siegal, T., Shalom, E., & Pe'er, J. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.127928 · Cited by 271
Voriconazole in the treatment of fungal eye infections: a review of current literature
Hariprasad, S. M., Mieler, W. F., Lin, T. K., Sponsel, W. E., & Graybill, J. R. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.136515 · Cited by 263
NELSON, M. L., TENNANT, M. T. S., SIVALINGAM, A., REGILLO, C. D., BELMONT, J. B., & MARTIDIS, A. (2003) · RETINA · doi:10.1097/00006982-200310000-00014 · Cited by 256
INTRAVITREAL INJECTION OF THERAPEUTIC AGENTS
PEYMAN, G. A., LAD, E. M., & MOSHFEGHI, D. M. (2009) · Retina · doi:10.1097/iae.0b013e3181a94f01 · Cited by 255
Intravitreal triamcinolone and elevated intraocular pressure
Fracs, R. J. B. W., & Fracs, P. E. B. (1999) · Australian and New Zealand Journal of Ophthalmology · doi:10.1046/j.1440-1606.1999.00238.x · Cited by 245
Outcome of Intravitreal Triamcinolone in Uveitis
Kok, H., Lau, C., Maycock, N., McCluskey, P., & Lightman, S. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.06.009 · Cited by 221
INCIDENCE OF ENDOPHTHALMITIS RELATED TO INTRAVITREAL INJECTION OF BEVACIZUMAB AND RANIBIZUMAB
FINTAK, D. R., SHAH, G. K., BLINDER, K. J., REGILLO, C. D., POLLACK, J., HEIER, J. S., HOLLANDS, H., & SHARMA, S. (2008) · Retina · doi:10.1097/iae.0b013e3181884fd2 · Cited by 214
Aminoglycoside Toxicity in the Treatment of Endophthalmitis
Campochiaro, P. A. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090130058017 · Cited by 199
Isenberg, S. J. (1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050090092039 · Cited by 192
Antoszyk, A. N., Tuomi, L., Chung, C. Y., & Singh, A. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.12.029 · Cited by 190
Treatment of Cytomegalovirus Retinitis with Intravitreal Ganciclovir
Cantrill, H. L., Henry, K., Melroe, N. H., Knobloch, W. H., Ramsay, R. C., & Balfour, H. H. (1989) · Ophthalmology · doi:10.1016/s0161-6420(89)32900-9 · Cited by 185
Complications of intravitreal injection of triamcinolone acetonide
Özkiriş, A., & Erkiliç, K. (2005) · Canadian Journal of Ophthalmology · doi:10.1016/s0008-4182(05)80119-x · Cited by 172
The Effect of Intravitreal Triamcinolone Acetonide on Intraocular Pressure
Bakri, S. J., & Beer, P. M. (2003) · Ophthalmic Surgery, Lasers and Imaging Retina · doi:10.3928/1542-8877-20030901-08 · Cited by 164
Avitabile, T., Longo, A., & Reibaldi, A. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.05.021 · Cited by 161
INCIDENCE OF ACUTE ONSET ENDOPHTHALMITIS FOLLOWING INTRAVITREAL BEVACIZUMAB (AVASTIN) INJECTION
MASON, J. O., WHITE, M. F., FEIST, R. M., THOMLEY, M. L., ALBERT, M. A., PERSAUD, T. O., YUNKER, J. J., & VAIL, R. S. (2008) · Retina · doi:10.1097/iae.0b013e3181633fee · Cited by 158
Cataract Formation and Other Complications of Intravitreal Triamcinolone for Macular Edema
Thompson, J. T. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.11.050 · Cited by 153
Intravitreal Ganciclovir in the Treatment of AIDS-associated Cytomegalovirus Retinitis
Ussery, F. M., Gibson, S. R., Conklin, R. H., Piot, D. F., Stool, E. W., & Conklin, A. J. (1988) · Ophthalmology · doi:10.1016/s0161-6420(88)33147-7 · Cited by 148
Long-term Intravitreal Ganciclovir Therapy for Cytomegalovirus Retinopathy
Heinemann, M. H. (1989) · Archives of Ophthalmology · doi:10.1001/archopht.1989.01070020849025 · Cited by 147
Lo, W. R., Rowlette, L. L. S., Caballero, M., Yang, P., Hernandez, M. R., & Borrás, T. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0444 · Cited by 136
Risk of Endophthalmitis After Intravitreal Drug Injection When Topical Antibiotics Are Not Required
Bhavsar, A. R. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.304 · Cited by 132
Singerman, L. J., Masonson, H., Patel, M., Adamis, A. P., Buggage, R. R., Cunningham, E. T., Goldbaum, M., Katz, B., & Guyer, D. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.132597 · Cited by 132
RISK OF ENDOPHTHALMITIS AFTER INTRAVITREAL DRUG INJECTION WHEN TOPICAL ANTIBIOTICS ARE NOT REQUIRED
Weisbrod, D. J., & Kertes, P. J. (2010) · Evidence-Based Ophthalmology · doi:10.1097/ieb.0b013e3181d5dc97 · Cited by 130
Intravitreal Silicone Oil Droplets After Intravitreal Drug Injections
Bakri, S. J., & Ekdawi, N. S. (2008) · Retina · doi:10.1097/iae.0b013e31816c6868 · Cited by 128
Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema
Moshfeghi, A. A., Scott, I. U., Flynn, H. W., & Puliafito, C. A. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.03.025 · Cited by 109
Gao, H. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.11.1687 · Cited by 105
Reducing the Risk of Endophthalmitis Following Intravitreal Injections
Scott, I. U., & Flynn, H. W. (2007) · Retina · doi:10.1097/iae.0b013e3180307271 · Cited by 101
INFECTIOUS ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTIANGIOGENIC AGENTS
Diago, T., McCannel, C. A., Bakri, S. J., Pulido, J. S., Edwards, A. O., & Pach, J. M. (2009) · Retina · doi:10.1097/iae.0b013e31819d2591 · Cited by 97
MINIMIZING THE RISK OF ENDOPHTHALMITIS FOLLOWING INTRAVITREOUS INJECTIONS
Ta, C. N. (2004) · Retina · doi:10.1097/00006982-200410000-00003 · Cited by 86
Retinal Toxicity of Intravitreal Gentamicin
Brown, G. C. (1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070140094037 · Cited by 86
Intraocular Methotrexate in Ocular Diseases Other Than Primary Central Nervous System Lymphoma
Hardwig, P. W., Pulido, J. S., Erie, J. C., Baratz, K. H., & Buettner, H. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.06.002 · Cited by 83
Clearance of Intravitreal Voriconazole
Shen, Y.-C., Wang, M.-Y., Wang, C.-Y., Tsai, T.-C., Tsai, H.-Y., Lee, Y., & Wei, L.-C. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1362 · Cited by 80
Safety and Efficacy of Intravitreal Triamcinolone Acetonide for Uveitic Macular Edema
Androudi, S. N., Letko, E., Meniconi, M., Papadaki, T., Ahmed, M., & Foster, C. S. (2005) · Ocular Immunology and Inflammation · doi:10.1080/09273940590933511 · Cited by 80
Presumed Sterile Endophthalmitis Following Intravitreal Triamcinolone Acetonide Injection
Moshfeghi, D. M., Kaiser, P. K., Bakri, S. J., Kaiser, R. S., Maturi, R. K., Sears, J. E., Scott, I. U., BELMONT, J. B., Beer, P. M., Quiroz–Mercado, H., et al. (2005) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/15428877-20050101-03 · Cited by 77
RETINAL TOXICITY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE: A Morphological Study
Yu, S., Damico, F. M., Viola, F., D’Amico, D. J., & YOUNG, L. H. Y. (2006) · Retina · doi:10.1097/00006982-200605000-00006 · Cited by 75
Hegazy, H. M., Kivilcim, M., Peyman, G. A., Ünal, M., Liang, C., Molinari, L. C., & Kazi, A. A. (1999) · Retina · doi:10.1097/00006982-199911000-00013 · Cited by 73
Karaçorlu, M., Özdemir, H., & Karaçorlu, S. (2003) · Acta Ophthalmologica Scandinavica · doi:10.1046/j.1395-3907.2003.0146.x · Cited by 69
Young, S. H., Morlet, N., Besen, G., Wiley, C. A., JONES, P. M., Gold, J., Li, Y., Freeman, W. R., & Coroneo, M. T. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)98020-4 · Cited by 65
Beck, R. W. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.109 · Cited by 64
Scott, I. U., Luu, K. M., & Davis, J. L. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.9.1219 · Cited by 61
Bucher, R. S., Hall, E. F., Reed, D. M., Richards, J. E., Johnson, M. W., & Zacks, D. N. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.5.649 · Cited by 61
SILICONE OIL DROPLETS FOLLOWING INTRAVITREAL INJECTION
Freund, K. B., Laud, K., Eandi, C. M., & Spaide, R. F. (2006) · Retina · doi:10.1097/01.iae.0000223177.08438.2b · Cited by 58
Frequency of Cataract Surgery after Intravitreal Injection of High-Dosage Triamcinolone Acetonide
Jonas, J. B., Degenring, R. F., Vossmerbauemer, U., & Kamppeter, B. A. (2005) · European Journal of Ophthalmology · doi:10.1177/112067210501500407 · Cited by 55
Scott, I. U., Oden, N. L., VanVeldhuisen, P., Ip, M. S., Blodi, B. A., & Antoszyk, A. N. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.06.004 · Cited by 52
RETINAL TOXICITY OF INTRAVITREAL KENALOG IN ALBINO RABBITS
Lang, Y., Zemel, E., Miller, B. T., & Perlman, I. (2007) · Retina · doi:10.1097/iae.0b013e318030c517 · Cited by 48
THE SAFETY OF INTRAOCULAR METHOTREXATE IN SILICONE-FILLED EYES
Hardwig, P. W., Pulido, J. S., & Bakri, S. J. (2008) · Retina · doi:10.1097/iae.0b013e3181754231 · Cited by 48
Krepler, K., Ergun, E., Sacu, S., Richter-Müksch, S., Wagner, J., Stur, M., & Wedrich, A. (2005) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2005.00490.x · Cited by 47
Ocular morbidity associated with intravitreal triamcinolone acetonide
Konstantopoulos, A., Williams, C. P. R., Newsom, R., & Luff, A. J. (2006) · Eye · doi:10.1038/sj.eye.6702416 · Cited by 47
Kernt, M., Neubauer, A. S., de Kaspar, H. M., & Kampik, A. (2009) · Retina · doi:10.1097/iae.0b013e31818d4b9b · Cited by 45
Sterile Endophthalmitis Following Intravitreal Injection of Triamcinolone Acetonide
Wang, L., & Yang, C. (2005) · Ocular Immunology and Inflammation · doi:10.1080/09273940590951007 · Cited by 45
PRIMARY INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR DIABETIC MASSIVE MACULAR HARD EXUDATES
Khairallah, M., Zeghidi, H., LADJIMI, A., Yahia, S. B., Attia, S., Zaouali, S., & Messaoud, R. (2005) · Retina · doi:10.1097/00006982-200510000-00003 · Cited by 38
Jonisch, J., Lai, J. C., DERAMO, V. A., Flug, A. J., & Fastenberg, D. M. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.136069 · Cited by 38
Hodge, W., Lalonde, R., Sampalis, J. S., & Deschênes, J. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.2.393 · Cited by 38
Jonas, J. B., Spandau, U. H., Harder, B. C., Vossmerbaeumer, U., & Kamppeter, B. A. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.01.032 · Cited by 34
Scedosporium apiospermum traumatic endophthalmitis successfully treated with voriconazole
Zarkovic, A., & Guest, S. (2007) · International Ophthalmology · doi:10.1007/s10792-007-9095-0 · Cited by 31
Baudouin, C., Chassain, C., Caujolle, C., & Gastaud, P. (2010) · Ophthalmologica · doi:10.1159/000310734 · Cited by 30
Islam, M. S., Vernon, S. A., & Negi, A. (2006) · Eye · doi:10.1038/sj.eye.6702304 · Cited by 27
Pseudohypopyon Following Intravitreal Triamcinolone Acetonide Injection
Sharma, M. C., Lai, W. W., & Shapiro, M. J. (2004) · Cornea · doi:10.1097/00003226-200405000-00016 · Cited by 26
Intravitreal triamcinolone injection for chronic diffuse diabetic macular oedema
Avcı, R., Kaderli, B., & Akalp, F. D. (2006) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2006.01103.x · Cited by 21
Lam, A., Garg, S. J., Spirn, M. J., Fineman, M. S., & Sivalingam, A. (2008) · Retinal Cases & Brief Reports · doi:10.1097/icb.0b013e31811324a0 · Cited by 11
Self-citationCurrent trends of intravitreal steroid use in retinal diseases
Mavrikakis, E., & Lam, W. (2009) · Canadian Journal of Ophthalmology · doi:10.3129/i09-039 · Cited by 6
Cited by
Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
Barrett, E. J., Liu, Z., Khamaisi, M., King, G. L., Klein, R., Klein, B. E. K., Hughes, T. M., Craft, S., Freedman, B. I., Bowden, D. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01922 · Cited by 515
Chan, C.-C., Rubenstein, J. L., Coupland, S. E., Davis, J. L., Harbour, J. W., Johnston, P. B., Cassoux, N., Touitou, V., Smith, J. R., Batchelor, T. T., et al. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0210 · Cited by 486
Martínez-Ballesta, M., Gil-Izquierdo, Á., García-Viguera, C., & Domínguez-Perles, R. (2018) · Foods · doi:10.3390/foods7050072 · Cited by 256
Müller Glia in Retinal Innate Immunity: A Perspective on Their Roles in Endophthalmitis
Kumar, A., Pandey, R. K., Miller, L. J., Singh, P. K., & Kanwar, M. (2013) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2013006618 · Cited by 99
Ocular drug delivery: advancements and innovations
Tian, B., Bilsbury, E., Doherty, S., Teebagy, S., Wood, E., Su, W., Gao, G., & Lin, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091931 · Cited by 50
Metadata
- Authors
- Sampat, K. M., & Garg, S. J.
- Venue
- Current Opinion in Ophthalmology
- Published
- 2010-05
- Volume
- 21
- Issue
- 3
- Pages
- 178-183
- ISSN
- 1040-8738 (ISSN-L)
- OpenAlex
- W2079546021
- Cited by
- 287
- References
- 80
- FWCI
- 19.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.